Kiniksa Pharmaceuticals Names Ross Moat President and Chief Operating Officer

• Kiniksa Pharmaceuticals appointed Ross Moat president and chief operating officer, effective immediately on October 17, 2026.
• Moat previously served as executive vice president and chief operating officer; he joined the company in June 2019.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001730430-26-000034), on October 22, 2026, and is solely responsible for the information contained therein.